17351256

Source:http://linkedlifedata.com/resource/pubmed/id/17351256

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0144576, umls-concept:C0205179, umls-concept:C0332174, umls-concept:C0546837, umls-concept:C0574032, umls-concept:C1442162, umls-concept:C1550718
pubmed:issue	5
pubmed:dateCreated	2007-5-9
pubmed:abstractText	The purpose of the study was to evaluate the efficacy of weekly paclitaxel (Taxol) in advanced esophageal cancer.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9007735
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, Phytogenic, http://linkedlifedata.com/resource/pubmed/chemical/Paclitaxel
pubmed:status	MEDLINE
pubmed:month	May
pubmed:issn	0923-7534
pubmed:author	pubmed-author:IlsonD HDH, pubmed-author:KelsenD PDP, pubmed-author:LeichmanL PLP, pubmed-author:WadleighR GRG
pubmed:issnType	Print
pubmed:volume	18
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	898-902
pubmed:meshHeading	pubmed-meshheading:17351256-Adenocarcinoma, pubmed-meshheading:17351256-Adult, pubmed-meshheading:17351256-Aged, pubmed-meshheading:17351256-Aged, 80 and over, pubmed-meshheading:17351256-Antineoplastic Agents, Phytogenic, pubmed-meshheading:17351256-Arthralgia, pubmed-meshheading:17351256-Carcinoma, Squamous Cell, pubmed-meshheading:17351256-Drug Administration Schedule, pubmed-meshheading:17351256-Esophageal Neoplasms, pubmed-meshheading:17351256-Female, pubmed-meshheading:17351256-Follow-Up Studies, pubmed-meshheading:17351256-Humans, pubmed-meshheading:17351256-Infusions, Intravenous, pubmed-meshheading:17351256-Male, pubmed-meshheading:17351256-Middle Aged, pubmed-meshheading:17351256-Neutropenia, pubmed-meshheading:17351256-Paclitaxel, pubmed-meshheading:17351256-Survival Analysis, pubmed-meshheading:17351256-Thrombocytopenia, pubmed-meshheading:17351256-Time Factors, pubmed-meshheading:17351256-Treatment Outcome
pubmed:year	2007
pubmed:articleTitle	Paclitaxel given by a weekly 1-h infusion in advanced esophageal cancer.
pubmed:affiliation	Memorial Sloan-Kettering Cancer Center, New York, NY, USA. ilsond@mskcc.org
pubmed:publicationType	Journal Article, Clinical Trial, Comparative Study, Multicenter Study